These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 10526669

  • 21. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, Chart P, Warner E.
    CMAJ; 2001 Apr 03; 164(7):1005-9. PubMed ID: 11314429
    [Abstract] [Full Text] [Related]

  • 22. Chemoprevention options for BRCA1 and BRCA2 mutation carriers.
    Eeles RA, Powles TJ.
    J Clin Oncol; 2000 Nov 01; 18(21 Suppl):93S-9S. PubMed ID: 11060334
    [Abstract] [Full Text] [Related]

  • 23. A survey of preventive measures among BRCA1 mutation carriers from Poland.
    Gronwald J, Byrski T, Huzarski T, Cybulski C, Stawicka M, Szwiec M, Debniak T, Tulman A, Sun P, Oszurek O, Lubinski J, Narod SA.
    Clin Genet; 2007 Feb 01; 71(2):153-7. PubMed ID: 17250664
    [Abstract] [Full Text] [Related]

  • 24. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D, Bremer M, Rades D, Skawran B, Siebrands C, Karstens JH, Dörk T.
    Br J Cancer; 2001 Sep 14; 85(6):850-8. PubMed ID: 11556836
    [Abstract] [Full Text] [Related]

  • 25. Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families.
    Vaziri SA, Krumroy LM, Rostai M, Casey G.
    Hum Mutat; 2001 Sep 14; 17(1):74. PubMed ID: 11139249
    [Abstract] [Full Text] [Related]

  • 26. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L.
    Cas Lek Cesk; 2000 Oct 11; 139(20):635-7. PubMed ID: 11192759
    [Abstract] [Full Text] [Related]

  • 27. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers.
    Shih HA, Nathanson KL, Seal S, Collins N, Stratton MR, Rebbeck TR, Weber BL.
    Clin Cancer Res; 2000 Nov 11; 6(11):4259-64. PubMed ID: 11106241
    [Abstract] [Full Text] [Related]

  • 28. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.
    Clin Cancer Res; 2002 Dec 11; 8(12):3776-81. PubMed ID: 12473589
    [Abstract] [Full Text] [Related]

  • 29. A genetic epidemiological study of carcinoma of the fallopian tube.
    Aziz S, Kuperstein G, Rosen B, Cole D, Nedelcu R, McLaughlin J, Narod SA.
    Gynecol Oncol; 2001 Mar 11; 80(3):341-5. PubMed ID: 11263928
    [Abstract] [Full Text] [Related]

  • 30. BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.
    Gershoni-Baruch R, Dagan E, Fried G, Kepten I, Robinson E.
    Eur J Hum Genet; 1999 Mar 11; 7(7):833-6. PubMed ID: 10573018
    [Abstract] [Full Text] [Related]

  • 31. Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland.
    Gronwald J, Byrski T, Huzarski T, Cybulski C, Sun P, Tulman A, Narod SA, Lubinski J.
    Breast Cancer Res Treat; 2006 Jan 11; 95(2):105-9. PubMed ID: 16261399
    [Abstract] [Full Text] [Related]

  • 32. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group.
    J Clin Oncol; 2008 Mar 01; 26(7):1093-7. PubMed ID: 18195327
    [Abstract] [Full Text] [Related]

  • 33. Psychological impact of receiving a BRCA1/BRCA2 test result.
    Lodder L, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ, Tibben A, Wagner A, van der Meer CA, van den Ouweland AM, Niermeijer MF.
    Am J Med Genet; 2001 Jan 01; 98(1):15-24. PubMed ID: 11426450
    [Abstract] [Full Text] [Related]

  • 34. Risk of breast cancer in carriers of BRCA gene mutations.
    Birkmeyer JD, Welch HG.
    N Engl J Med; 1997 Sep 11; 337(11):787-8; author reply 789. PubMed ID: 9289638
    [No Abstract] [Full Text] [Related]

  • 35. [Genetic test and prophylactic treatment in breast cancer families].
    Miyoshi Y, Noguchi S.
    Gan To Kagaku Ryoho; 2002 Apr 11; 29(4):512-22. PubMed ID: 11977534
    [Abstract] [Full Text] [Related]

  • 36. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB.
    Cancer Epidemiol Biomarkers Prev; 2001 May 11; 10(5):467-73. PubMed ID: 11352856
    [Abstract] [Full Text] [Related]

  • 37. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Australian Ovarian Cancer Study Management Group.
    J Natl Cancer Inst; 2008 Nov 05; 100(21):1519-29. PubMed ID: 18957670
    [Abstract] [Full Text] [Related]

  • 38. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
    Lerman C, Hughes C, Croyle RT, Main D, Durham C, Snyder C, Bonney A, Lynch JF, Narod SA, Lynch HT.
    Prev Med; 2000 Jul 05; 31(1):75-80. PubMed ID: 10896846
    [Abstract] [Full Text] [Related]

  • 39. Risk of breast cancer in carriers of BRCA gene mutations.
    Orlando R.
    N Engl J Med; 1997 Sep 11; 337(11):787; author reply 789. PubMed ID: 9289637
    [No Abstract] [Full Text] [Related]

  • 40. [INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer].
    Eisinger F, Alby N, Bremond A, Dauplat J, Espié M, Janiaud P, Kuttenn F, Lebrun JP, Lefranc JP, Pierret J, Sobol H, Stoppa-Lyonnet D, Thouvenin D, Tristant H, Feingold J.
    Ann Genet; 1999 Sep 11; 42(1):51-64. PubMed ID: 10214508
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.